Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

793 ARTÍCULOS , VIENDO DEL 91 AL 105

Gerstmann-Sträussler-Scheinker disease: A case report

Zhao MM, Feng LS, Hou S, Shen PP, Cui L, Feng JC.

World J Clin Cases. 2019 Feb 6;7(3):389-395. doi: 10.12998/wjcc.v7.i3.389.

Spinocerebellar Ataxia Type 2

Pulst SM.

1998 Oct 23 [updated 2019 Feb 14]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Reversible myoclonus-ataxia encephalitis related to anti-mGLUR1 autoantibodies

Gollion C, Dupouy J, Roberts M, Simonetta-Moreau M, Brefel Courbon C, Rascol O, Honnorat J, Magne FO.

Mov Disord. 2019 Mar;34(3):438-439. doi: 10.1002/mds.27634. Epub 2019 Feb 13.

Neurological Manifestations of Neuropathy and Ataxia in Celiac Disease: A Systematic Review

Mearns ES, Taylor A, Thomas Craig KJ, Puglielli S, Leffler DA, Sanders DS, Lebwohl B, Hadjivassiliou M.

Nutrients. 2019 Feb 12;11(2):380. doi: 10.3390/nu11020380.

DNA damage as a marker of brain damage in individuals with history of concussions

Schwab N, Tator C, Hazrati LN.

Lab Invest. 2019 Jul;99(7):1008-1018. doi: 10.1038/s41374-019-0199-8. Epub 2019 Feb 13.

MT-ATP6 mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new cases

Ganetzky RD, Stendel C, McCormick EM, Zolkipli-Cunningham Z, Goldstein AC, Klopstock T, Falk MJ.

Hum Mutat. 2019 May;40(5):499-515. doi: 10.1002/humu.23723. Epub 2019 Mar 4.

Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma

Ren W, Xue B, Chen M, Liu L, Zu X.

Clin Genitourin Cancer. 2019 Jun;17(3):e433-e439. doi: 10.1016/j.clgc.2019.01.003. Epub 2019 Jan 10.

Homozygous variant in OTX2 and possible genetic modifiers identified in a patient with combined pituitary hormone deficiency, ocular involvement, myopathy, ataxia, and mitochondrial impairment

Catania A, Legati A, Peverelli L, Nanetti L, Marchet S, Zanetti N, Lamperti C, Ghezzi D.

Am J Med Genet A. 2019 May;179(5):827-831. doi: 10.1002/ajmg.a.61092. Epub 2019 Feb 17.

Effects of Intramuscular Alfaxalone/Acepromazine on Echocardiographic, Biochemical, and Blood Gas Measurements in Healthy Cats

Kim B, Jang M, Sohn J, Oh H, Jo S, Choi M, Lee I, Yoon J.

J Am Anim Hosp Assoc. 2019 Mar/Apr;55(2):70-77. doi: 10.5326/JAAHA-MS-6630. Epub 2019 Jan 17.

Clinically Significant Drug-Drug Interactions Involving Medications Used for Symptom Control in Patients With Advanced Malignant Disease: A Systematic Review

Kotlinska-Lemieszek A, Klepstad P, Haugen DF.

J Pain Symptom Manage. 2019 May;57(5):989-998.e1. doi: 10.1016/j.jpainsymman.2019.02.006. Epub 2019 Feb 16.

Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)

Becherel OJ, Fogel BL, Zeitlin SI, Samaratunga H, Greaney J, Homer H, Lavin MF.

Cerebellum. 2019 Jun;18(3):448-456. doi: 10.1007/s12311-019-01012-w.

Pseudo-ataxia due to Osteoid Osteoma

McKenzie J, Oettel-Flaherty C, Noel D, Walker RH, Sobering AK.

Tremor Other Hyperkinet Mov (N Y). 2019 Feb 6;9:631. doi: 10.7916/vt1n-ga19. eCollection 2019.

VPS13D Movement Disorder

Meijer IA.

2019 Feb 21. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Guidelines on the diagnosis and management of the progressive ataxias

de Silva R, Greenfield J, Cook A, Bonney H, Vallortigara J, Hunt B, Giunti P.

Orphanet J Rare Dis. 2019 Feb 20;14(1):51. doi: 10.1186/s13023-019-1013-9.

Paraneoplastic opsoclonus-myoclonus syndrome as a rare presentation of breast cancer

Martins L, Galvão D, Silva A, Vieira B, Reis Ó, Vitorino R, Pires P.

J Surg Case Rep. 2019 Feb 8;2019(2):rjy365. doi: 10.1093/jscr/rjy365. eCollection 2019 Feb.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias